Nbt Bank N A Gilead Sciences, Inc. Transaction History

Nbt Bank N A

$1.35 Billion
Q1 2024

A detailed history of Nbt Bank N A transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nbt Bank N A holds 9,966 shares of GILD stock, worth $673,203. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,966

Previous 10,296 3.21%

Holding current value

$673,203

Previous $834,000 12.47%

% of portfolio

0.05%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $23,621 - $28,805	-330 Reduced 3.21%	9,966 $730,000
Q3 2023 Oct 26, 2023	BUY	$73.94 - $80.67 $287,109 - $313,241	3,883 Added 60.55%	10,296 $771,000
Q2 2023 Jul 24, 2023	BUY	$76.01 - $86.7 $26,299 - $29,998	346 Added 5.7%	6,413 $494,000
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $11,404 - $16,373	-183 Reduced 2.93%	6,067 $520,000
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $203,448 - $232,390	-3,417 Reduced 35.35%	6,250 $386,000

Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $57 - $65	-1 Reduced 0.01%	9,667 $597,000
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $31,392 - $39,338	-542 Reduced 5.31%	9,668 $575,000
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $2,595 - $2,945	-40 Reduced 0.39%	10,210 $742,000
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $3,808 - $4,161	-60 Reduced 0.58%	10,250 $705,000
Q1 2021 Apr 08, 2021	BUY	$60.0 - $68.46 $33,000 - $37,653	550 Added 5.64%	10,310 $667,000
Q4 2020 Jan 15, 2021	BUY	$56.65 - $64.55 $57,726 - $65,776	1,019 Added 11.66%	9,760 $569,000
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $5,589 - $7,027	-90 Reduced 1.02%	8,741 $553,000
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $19,170 - $22,260	265 Added 3.09%	8,831 $680,000
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $34,446 - $44,121	550 Added 6.86%	8,566 $640,000
Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $166,990 - $183,683	2,710 Added 51.07%	8,016 $521,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $43,694 - $48,231	699 Added 15.17%	5,306 $336,000
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $6,187 - $6,938	-100 Reduced 2.12%	4,607 $311,000
Q1 2019 May 06, 2019	SELL	$62.53 - $70.05 $30,827 - $34,534	-493 Reduced 9.48%	4,707 $306,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $62,779 - $81,923	-1,037 Reduced 16.63%	5,200 $325,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $187,894 - $208,033	-2,636 Reduced 29.71%	6,237 $482,000
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $619,474 - $722,592	-9,548 Reduced 51.83%	8,873 $629,000
Q1 2018 May 22, 2018	SELL	$72.84 - $88.8 $144,805 - $176,534	-1,988 Reduced 9.74%	18,421 $1.39 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.33 Million - $1.57 Million	-18,757 Reduced 47.89%	20,409 $1.46 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $308,198 - $365,298	4,274 Added 12.25%	39,166 $3.17 Million
Q2 2017 Aug 08, 2017	BUY	N/A	34,892	34,892 $2.47 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account